{"id":517440,"date":"2021-07-26T08:33:25","date_gmt":"2021-07-26T12:33:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/"},"modified":"2021-07-26T08:33:25","modified_gmt":"2021-07-26T12:33:25","slug":"minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/","title":{"rendered":"Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021"},"content":{"rendered":"<h2>\nManagement to host conference call<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>WALTHAM, Mass., July  26, 2021  (GLOBE NEWSWIRE) &#8212; Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release financial results and business updates for the second quarter of 2021 on Monday, August 2, 2021. The Company will host a webcast and conference call that day at 8:30 a.m. Eastern Time to discuss these results and updates.<\/p>\n<p>The live call may be accessed by dialing (877) 312-5845 (domestic) or (765) 507-2618 (international) and referring to conference ID number 4327209. A live webcast of the conference call will be available online in the Investors and Media section of the Company\u2019s website at ir.minervaneurosciences.com. The archived webcast will be available on the Company\u2019s website beginning approximately two hours after the event for 30 days.<\/p>\n<p>The live webcast can be accessed under \u201cEvents and Presentations\u201d in the Investors and Media section of Minerva\u2019s website at ir.minervaneurosciences.com. The archived webcast will be available on the website beginning approximately two hours after the event for 90 days.<\/p>\n<p>\n        <strong>About Minerva Neurosciences<\/strong>\n      <\/p>\n<p>Minerva\u2019s portfolio of compounds includes: roluperidone (MIN-101), in clinical development for schizophrenia, and MIN-301, in pre-clinical development for Parkinson\u2019s disease. Minerva\u2019s common stock is listed on the NASDAQ Global Market under the symbol \u201cNERV.\u201d\u00a0For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jh0wcoM5alcyb9-URKURWg2KhWvPuF3iQMyCqwE-DrF06aEs_B1I6NFSQkxDiGrihVE43GPL4XNa4nJ6287N3gCv2Rwdi-JH7nU2LUjwTbKIvggdOkbiNjK_GU7BFDd9\" rel=\"nofollow noopener\" target=\"_blank\">www.minervaneurosciences.com<\/a>.<\/p>\n<p>\n        <strong><br \/>\n          <u>Contact<\/u><br \/>\n        <\/strong>:<\/p>\n<p>William B. Boni<br \/>VP, Investor Relations\/<br \/>Corp. Communications<br \/>Minerva Neurosciences, Inc.<br \/>(617) 600-7376\u00a0\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDMwMyM0MzA3OTI4IzIwMDcyNDU=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/313c2032-e8c0-456e-a1e2-2bafba790cae\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Management to host conference call WALTHAM, Mass., July 26, 2021 (GLOBE NEWSWIRE) &#8212; Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release financial results and business updates for the second quarter of 2021 on Monday, August 2, 2021. The Company will host a webcast and conference call that day at 8:30 a.m. Eastern Time to discuss these results and updates. The live call may be accessed by dialing (877) 312-5845 (domestic) or (765) 507-2618 (international) and referring to conference ID number 4327209. A live webcast of the conference call will be available online in the Investors and Media section of the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-517440","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Management to host conference call WALTHAM, Mass., July 26, 2021 (GLOBE NEWSWIRE) &#8212; Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release financial results and business updates for the second quarter of 2021 on Monday, August 2, 2021. The Company will host a webcast and conference call that day at 8:30 a.m. Eastern Time to discuss these results and updates. The live call may be accessed by dialing (877) 312-5845 (domestic) or (765) 507-2618 (international) and referring to conference ID number 4327209. A live webcast of the conference call will be available online in the Investors and Media section of the &hellip; Continue reading &quot;Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-26T12:33:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDMwMyM0MzA3OTI4IzIwMDcyNDU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021\",\"datePublished\":\"2021-07-26T12:33:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\\\/\"},\"wordCount\":253,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NDMwMyM0MzA3OTI4IzIwMDcyNDU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\\\/\",\"name\":\"Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NDMwMyM0MzA3OTI4IzIwMDcyNDU=\",\"datePublished\":\"2021-07-26T12:33:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NDMwMyM0MzA3OTI4IzIwMDcyNDU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NDMwMyM0MzA3OTI4IzIwMDcyNDU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/","og_locale":"en_US","og_type":"article","og_title":"Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021 - Market Newsdesk","og_description":"Management to host conference call WALTHAM, Mass., July 26, 2021 (GLOBE NEWSWIRE) &#8212; Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release financial results and business updates for the second quarter of 2021 on Monday, August 2, 2021. The Company will host a webcast and conference call that day at 8:30 a.m. Eastern Time to discuss these results and updates. The live call may be accessed by dialing (877) 312-5845 (domestic) or (765) 507-2618 (international) and referring to conference ID number 4327209. A live webcast of the conference call will be available online in the Investors and Media section of the &hellip; Continue reading \"Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-26T12:33:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDMwMyM0MzA3OTI4IzIwMDcyNDU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021","datePublished":"2021-07-26T12:33:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/"},"wordCount":253,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDMwMyM0MzA3OTI4IzIwMDcyNDU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/","name":"Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDMwMyM0MzA3OTI4IzIwMDcyNDU=","datePublished":"2021-07-26T12:33:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDMwMyM0MzA3OTI4IzIwMDcyNDU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDMwMyM0MzA3OTI4IzIwMDcyNDU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-report-second-quarter-2021-financial-results-and-business-updates-on-august-2-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=517440"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517440\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=517440"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=517440"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=517440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}